Pengaruh Celebrity Endorsement, Brand Image Dan Brand Trust Terhadap Keputusan Pembelian Produk (Studi pada Somethinc by Irene Ursula)

Penelitian ini bertujuan untuk mengetahui Pengaruh Celebroty Endorsement,Brand Image dan Brand Trust terhadap Keputusan Pembelian Produk Somethinc. Dalam penelitian ini peneliti menggunakan metode pengumpulan data dengan cara melakukan penyebaran kuesioner. Analisis data selanjutnya menggunakan uji analisis linier berganda, uji t, uji f dan korfisien determinan. Hasil analisis diperoleh bahwa uji regresi berganda persamaan adalah : Y=0,217 (X1)+0,360 (X2)+0,387 (X3). Hasil uji t variabel celebrity endorsement ( X1) terhadap keputusan pembelian (Y) yaitu sebesar 3.031<1.660, dan variabel brand image (X2) terhadap keputusan pembelian (Y) yaitu sebesar 4.219 <1.660, dan variabel brand trust (X3) terhadap keputusan pembelian (Y) yaitu sebesar 4.480 < 1.660. semua hal ini menunjukkan bahwa celebrity endorsement, brand image dan brand trust berpengaruh secara positif terhadap keputusan pembelian (Y) pada Produk Somethinc

Landsat-8, advanced spaceborne thermal emission and reflection radiometer, and WorldView-3 multispectral satellite imagery for prospecting copper-gold mineralization in the northeastern Inglefield Mobile Belt (IMB), northwest Greenland

© 2019 by the authors. Several regions in the High Arctic still lingered poorly explored for a variety of mineralization types because of harsh climate environments and remoteness. Inglefield Land is an ice-free region in northwest Greenland that contains copper-gold mineralization associated with hydrothermal alteration mineral assemblages. In this study, Landsat-8, Advanced Spaceborne Thermal Emission and Reflection Radiometer (ASTER), and WorldView-3 multispectral remote sensing data were used for hydrothermal alteration mapping and mineral prospecting in the Inglefield Land at regional, local, and district scales. Directed principal components analysis (DPCA) technique was applied to map iron oxide/hydroxide, Al/Fe-OH, Mg-Fe-OH minerals, silicification (Si-OH), and SiO2 mineral groups using specialized band ratios of the multispectral datasets. For extracting reference spectra directly from the Landsat-8, ASTER, and WorldView-3 (WV-3) images to generate fraction images of end-member minerals, the automated spectral hourglass (ASH) approach was implemented. Linear spectral unmixing (LSU) algorithm was thereafter used to produce a mineral map of fractional images. Furthermore, adaptive coherence estimator (ACE) algorithm was applied to visible and near-infrared and shortwave infrared (VINR + SWIR) bands of ASTER using laboratory reflectance spectra extracted from the USGS spectral library for verifying the presence of mineral spectral signatures. Results indicate that the boundaries between the Franklinian sedimentary successions and the Etah metamorphic and meta-igneous complex, the orthogneiss in the northeastern part of the Cu-Au mineralization belt adjacent to Dallas Bugt, and the southern part of the Cu-Au mineralization belt nearby Marshall Bugt show high content of iron oxides/hydroxides and Si-OH/SiO2 mineral groups, which warrant high potential for Cu-Au prospecting. A high spatial distribution of hematite/jarosite, chalcedony/opal, and chlorite/epidote/biotite were identified with the documented Cu-Au occurrences in central and southwestern sectors of the Cu-Au mineralization belt. The calculation of confusion matrix and Kappa Coefficient proved appropriate overall accuracy and good rate of agreement for alteration mineral mapping. This investigation accomplished the application of multispectral/multi-sensor satellite imagery as a valuable and economical tool for reconnaissance stages of systematic mineral exploration projects in remote and inaccessible metallogenic provinces around the world, particularly in the High Arctic regions

Diversifying search in bee algorithms for numerical optimisation

© Springer Nature Switzerland AG 2018. Swarm intelligence offers useful instruments for developing collective behaviours to solve complex, ill-structured and large-scale problems. Efficiency in collective behaviours depends on how to harmonise the individual contributions so that a complementary collective effort can be achieved to offer a useful solution. The harmonisation helps blend diversification and intensification suitably towards efficient collective behaviours. In this study, two renown honeybees-inspired algorithms were analysed with respect to the balance of diversification and intensification and a hybrid algorithm is proposed to improve the efficiency accordingly. The proposed hybrid algorithm was tested with solving well-known highly dimensional numerical optimisation (benchmark) problems. Consequently, the proposed hybrid algorithm has demonstrated outperforming the two original bee algorithms in solving hard numerical optimisation benchmarks

Identification of phyllosilicates in the antarctic environment using aster satellite data: Case study from the mesa range, campbell and priestley glaciers, northern Victoria land

In Antarctica, spectral mapping of altered minerals is very challenging due to the remote-ness and inaccessibility of poorly exposed outcrops. This investigation evaluates the capability of Advanced Spaceborne Thermal Emission and Reflection Radiometer (ASTER) satellite remote sensing imagery for mapping and discrimination of phyllosilicate mineral groups in the Antarctic environment of northern Victoria Land. The Mixture-Tuned Matched-Filtering (MTMF) and Constrained Energy Minimization (CEM) algorithms were used to detect the sub-pixel abundance of Al-rich, Fe -rich, Fe -rich and Mg-rich phyllosilicates using the visible and near-infrared (VNIR), short-wave infrared (SWIR) and thermal-infrared (TIR) bands of ASTER. Results indicate that Al-rich phyllosilicates are strongly detected in the exposed outcrops of the Granite Harbour granitoids, Wilson Metamorphic Complex and the Beacon Supergroup. The presence of the smectite mineral group derived from the Jurassic basaltic rocks (Ferrar Dolerite and Kirkpatrick Basalts) by weathering and decomposition processes implicates Fe -rich and Fe -rich phyllosilicates. Biotite (Fe -rich phyllosilicate) is detected associated with the Granite Harbour granitoids, Wilson Metamorphic Complex and Melbourne Volcanics. Mg-rich phyllosilicates are mostly mapped in the scree, glacial drift, moraine and crevasse fields derived from weathering and decomposition of the Kirkpatrick Basalt and Ferrar Dolerite. Chlorite (Mg-rich phyllosilicate) was generally mapped in the exposures of Granite Harbour granodiorite and granite and partially identified in the Ferrar Dolerite, the Kirkpatrick Basalt, the Priestley Formation and Priestley Schist and the scree, glacial drift and moraine. Statistical results indicate that Al-rich phyllosilicates class pixels are strongly discriminated, while the pixels at-tributed to Fe -rich class, Fe -rich and Mg-rich phyllosilicates classes contain some spectral mixing due to their subtle spectral differences in the VNIR+SWIR bands of ASTER. Results derived from TIR bands of ASTER show that a high level of confusion is associated with mafic phyllosilicates pixels (Fe -rich, Fe -rich and Mg-rich classes), whereas felsic phyllosilicates (Al-rich class) pixels are well mapped. Ground truth with detailed geological data, petrographic study and X-ray diffraction (XRD) analysis verified the remote sensing results. Consequently, ASTER image-map of phyllosilicate minerals is generated for the Mesa Range, Campbell and Priestley Glaciers, northern Victoria Land of Antarctica. 3+ 2+ 3+ 2+ 2+ 3+ 2+ 3+ 2

Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia

BackgroundCritical limb ischemia (CLI) constitutes the most aggressive form of peripheral arterial occlusive disease, characterized by the blockade of arteries supplying blood to the lower extremities, significantly diminishing oxygen and nutrient supply. CLI patients usually undergo amputation of fingers, feet, or extremities, with a high risk of mortality due to associated comorbidities.Circulating angiogenic cells (CACs), also known as early endothelial progenitor cells, constitute promising candidates for cell therapy in CLI due to their assigned vascular regenerative properties. Preclinical and clinical assays with CACs have shown promising results. A better understanding of how these cells participate in vascular regeneration would significantly help to potentiate their role in revascularization.Herein, we analyzed the initial molecular mechanisms triggered by human CACs after being administered to a murine model of CLI, in order to understand how these cells promote angiogenesis within the ischemic tissues.MethodsBalb-c nude mice (n:24) were distributed in four different groups: healthy controls (C, n:4), shams (SH, n:4), and ischemic mice (after femoral ligation) that received either 50 mu l physiological serum (SC, n:8) or 5x10(5) human CACs (SE, n:8). Ischemic mice were sacrificed on days 2 and 4 (n:4/group/day), and immunohistochemistry assays and qPCR amplification of Alu-human-specific sequences were carried out for cell detection and vascular density measurements. Additionally, a label-free MS-based quantitative approach was performed to identify protein changes related.ResultsAdministration of CACs induced in the ischemic tissues an increase in the number of blood vessels as well as the diameter size compared to ischemic, non-treated mice, although the number of CACs decreased within time. The initial protein changes taking place in response to ischemia and more importantly, right after administration of CACs to CLI mice, are shown.ConclusionsOur results indicate that CACs migrate to the injured area; moreover, they trigger protein changes correlated with cell migration, cell death, angiogenesis, and arteriogenesis in the host. These changes indicate that CACs promote from the beginning an increase in the number of vessels as well as the development of an appropriate vascular network.Institute of Health Carlos III, ISCIII; Junta de Andaluci

Comparison of silicon oil removal with various viscosities after complex retinal detachment surgery

BACKGROUND: Despite the progress in vitreoretinal surgery and the importance of silicone oil as an adjunct for the treatment of complex forms of retinal detachment, controversy still surrounds the issue of selecting the proper oil viscosity for clinical use. Herein, we evaluate the outcomes of retinal detachment (RD) surgery after removing silicone oils of different viscosities. METHODS: In this retropsective cohort study, eighty-two eyes with surgically re-attached retinas, of which 53 were filled with 5000cs silicone oil and 29 with 1000cs silicone oil were enrolled. We evaluated the outcomes and complications following silicone oil removal. Final anatomic success (stable re-attachment), final visual acuity (VA) and intraocular pressure (IOP)were recorded and analysed. RESULTS: Of 82 eyes, 41 had proliferative vitreoretinopathy (PVR), 24 were associated with intraocular foreign bodies, 10 had endophthalmitis and 7 had proliferative diabetic retinopathy with tractional retinal detachment. Prior to silicone oil removal, the retina was attached in all eyes, 29% had VA ≥ 6/120 and 52% had IOP ≥ 21 mmHg. After silicone oil removal, the retina remained attached in 59(72%) of the eyes, 34% had VA ≥ 6/120 and 9% had IOP ≥ 21 mmHg. Comparing 1000cs and 5000cs silicone oil filled eyes, redetachment occurred more frequently in the latter group especially in cases with associated PVR. Final VA worse than 6/120 was associated with initial VA < 6/120 (OR = 32.2 95%CI 7.4–140.2) and use of 5000cs silicone oil (OR = 7.9 95%CI 1.9–32.2). No factor was significantly associated with final IOP ≥ 21 mmHg. CONCLUSION: In complicated retinal detachment surgery, use of 5000cs silicone oil may be associated with a poorer anatomic and visual outcome compared with 1000cs silicone oil. However there was no difference between the two viscosities in IOP elevation. A randomized controlled study is necessary to further evaluate such a possibility

Search for supersymmetric particles in scenarios with a gravitino LSP and stau NLSP

Sleptons, neutralinos and charginos were searched for in the context of scenarios where the lightest supersymmetric particle is the gravitino. It was assumed that the stau is the next-to-lightest supersymmetric particle. Data collected with the DELPHI detector at a centre-of-mass energy near 189 GeV were analysed combining the methods developed in previous searches at lower energies. No evidence for the production of these supersymmetric particles was found. Hence, limits were derived at 95% confidence level.Comment: 31 pages, 14 figure

Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells

Histone deacetylase inhibitors (HDACi) are promising anti-cancer agents, however, their mechanisms of action remain unclear. In acute myeloid leukemia (AML) cells, HDACi have been reported to arrest growth and induce apoptosis. In this study, we elucidate details of the DNA damage induced by the HDACi vorinostat in AML cells. At clinically relevant concentrations, vorinostat induces double-strand breaks and oxidative DNA damage in AML cell lines. Additionally, AML patient blasts treated with vorinostat display increased DNA damage, followed by an increase in caspase-3/7 activity and a reduction in cell viability. Vorinostat-induced DNA damage is followed by a G2-M arrest and eventually apoptosis. We found that pre-treatment with the antioxidant N-acetyl cysteine (NAC) reduces vorinostat-induced DNA double strand breaks, G2-M arrest and apoptosis. These data implicate DNA damage as an important mechanism in vorinostat-induced growth arrest and apoptosis in both AML cell lines and patient-derived blasts. This supports the continued study and development of vorinostat in AMLs that may be sensitive to DNA-damaging agents and as a combination therapy with ionizing radiation and/or other DNA damaging agents

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

The effects of sorafenib – an oral multikinase inhibitor targeting the tumour and tumour vasculature – were evaluated in patients with advanced melanoma enrolled in a large multidisease Phase II randomised discontinuation trial (RDT). Enrolled patients received a 12-week run-in of sorafenib 400 mg twice daily (b.i.d.). Patients with changes in bi-dimensional tumour measurements <25% from baseline were then randomised to sorafenib or placebo for a further 12 weeks (ie to week 24). Patients with ⩾25% tumour shrinkage after the run-in continued on open-label sorafenib, whereas those with ⩾25% tumour growth discontinued treatment. This analysis focussed on secondary RDT end points: changes in bi-dimensional tumour measurements from baseline after 12 weeks and overall tumour responses (WHO criteria) at week 24, progression-free survival (PFS), safety and biomarkers (BRAF, KRAS and NRAS mutational status). Of 37 melanoma patients treated during the run-in phase, 34 were evaluable for response: one had ⩾25% tumour shrinkage and remained on open-label sorafenib; six (16%) had <25% tumour growth and were randomised (placebo, n=3; sorafenib, n=3); and 27 had ⩾25% tumour growth and discontinued. All three randomised sorafenib patients progressed by week 24; one remained on sorafenib for symptomatic relief. All three placebo patients progressed by week-24 and were re-started on sorafenib; one experienced disease re-stabilisation. Overall, the confirmed best responses for each of the 37 melanoma patients who received sorafenib were 19% stable disease (SD) (ie n=1 open-label; n=6 randomised), 62% (n=23) progressive disease (PD) and 19% (n=7) unevaluable. The overall median PFS was 11 weeks. The six randomised patients with SD had overall PFS values ranging from 16 to 34 weeks. The most common drug-related adverse events were dermatological (eg rash/desquamation, 51%; hand-foot skin reaction, 35%). There was no relationship between V600E BRAF status and disease stability. DNA was extracted from the biopsies of 17/22 patients. Six had V600E-positive tumours (n=4 had PD; n=1 had SD; n=1 unevaluable for response), and 11 had tumours containing wild-type BRAF (n=9 PD; n=1 SD; n=1 unevaluable for response). In conclusion, sorafenib is well tolerated but has little or no antitumour activity in advanced melanoma patients as a single agent at the dose evaluated (400 mg b.i.d.). Ongoing trials in advanced melanoma are evaluating sorafenib combination therapies